Ascendis Pharma A/S

(NASDAQ:ASND)

Latest On Ascendis Pharma A/S (ASND):

Date/Time Type Description Signal Details
2023-05-08 18:47 ESTNewsAscendis Pharma added to Wedbush's best ideas listN/A
2023-05-02 17:38 ESTNewsAscendis Pharma Q1 Earnings: Skytrofa Soars, PTH Hurdles Yet To ClearN/A
2023-05-01 17:06 ESTNewsAscendis' TransCon gets FDA rejection but company hopeful as no new trials requestedN/A
2023-04-28 02:05 ESTNewsAscendis Pharma A/S (ASND) Q1 2023 Earnings Call TranscriptN/A
2023-04-27 01:02 ESTNewsAscendis Pharma Q1 2023 Earnings PreviewN/A
2023-04-20 16:46 ESTNewsAscendis Pharma: A Promising Diversification PlayN/A
2023-04-17 01:29 ESTNewsAscendis Pharma: Recent FDA Setbacks Present A Buying OpportunityN/A
2023-04-06 23:12 ESTNewsAscendis Pharma: Is Dip On TransCon Application A Buy Opportunity?N/A
2023-04-03 14:24 ESTNewsAscendis stock slumps ~35% after FDA finds 'deficiencies' in TransCon applicationN/A
2023-04-03 14:24 ESTNewsAscendis downgraded at Credit Suisse on deficiencies in drug applicationN/A
2023-02-17 11:10 ESTNewsAscendis Pharma A/S (ASND) Q4 2022 Earnings Call TranscriptN/A
2023-02-16 22:05 ESTNewsAscendis Pharma GAAP EPS of -€10.40, revenue of €51.17MN/A
2023-02-15 19:21 ESTNewsAscendis Pharma FY 2022 Earnings PreviewN/A
2023-01-27 16:41 ESTNewsAscendis: Neutral On Skytrofa's Market Launch, Initiating With A Neutral RatingN/A
2023-01-19 02:12 ESTNewsAscendis Pharma: Group's Best Nearby Capital Gain Price-Position StockN/A
2022-11-17 14:37 ESTNewsAscendis, Visen' once-weekly growth hormone drug beats daily hGH in Chinese patients in trialN/A
2022-11-14 19:34 ESTNewsAscendis falls on Phase 2 data for achondroplasia candidateN/A
2022-11-05 05:43 ESTNewsAscendis Pharma A/S (ASND) Q3 2022 Earnings Call TranscriptN/A
2022-11-04 12:46 ESTNewsAscendis Pharma: Translating Valuable IP Into A Profitable BusinessN/A
2022-11-03 02:59 ESTNewsAscendis Pharma GAAP EPS of -€3.03, revenue of €15.29MN/A
2022-11-01 19:43 ESTNewsAscendis Pharma Q3 2022 Earnings PreviewN/A
2022-11-01 03:36 ESTNewsAscendis parathyroid hormone therapy goes under FDA priority reviewN/A
2022-09-16 02:59 ESTNewsAscendis Pharma: TransCon CNP Data Coming Q4N/A
2022-08-31 23:18 ESTNewsAscendis Pharma seeks FDA nod for its parathyroid hormone restorer TransCon PTHN/A
2022-08-11 20:08 ESTNewsAscendis Pharma Q2 results beat buoyed by strong sales of growth hormone drug SkytrofaN/A
2022-08-11 03:38 ESTNewsAscendis Pharma GAAP EPS of -€1.46 beats by €0.69, revenue of €6.16B beats by $6.15BN/A
2022-08-11 03:37 ESTNewsAscendis Pharma A/S (ASND) CEO Jan Mikkelsen on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-10 09:43 ESTNewsAscendis Pharma Q2 2022 Earnings PreviewN/A
2022-08-04 05:34 ESTNewsAscendis Pharma: Institutional Buying Values Dutch Biotech Best-Now Cap-Gain ProspectN/A
2022-05-23 09:02 ESTNewsAscendis, Visen' TransCon hGH meets main goal in growth hormone deficiency China trial in childrenN/A
2022-05-13 04:45 ESTNewsAscendis Pharma slides after Street analysts cut price target over SKYTROFA revenue missN/A
2022-05-12 09:00 ESTNewsAscendis Pharma GAAP EPS of -€2.21 misses by €0.05, revenue of €6.83M beats by €1.98MN/A
2022-05-12 09:00 ESTNewsAscendis Pharma A/S (ASND) CEO Jan Mikkelsen on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-10 19:27 ESTNewsAscendis Pharma Q1 2022 Earnings PreviewN/A
2022-05-09 22:24 ESTNewsAscendis Pharma: Biotech Bear Provides Attractive Entry PointN/A
2022-04-29 17:39 ESTNewsAscendis: Institutional Buying Activity Now Seen As Good Value By Market-MakersN/A
2022-03-25 08:03 ESTNewsAscendis Pharma prices $500.0M convertible senior notes offeringN/A
2022-03-23 22:32 ESTNewsAscendis Pharma slides on offering of $500M convertible senior notesN/A
2022-03-16 20:02 ESTNewsAscendis posts biggest intraday gain in six months as BofA upgrades on trial resultsN/A
2022-03-14 20:55 ESTNewsAscendis Pharma TransCon PTH for hypoparathyroidism meets main goal in phase 3 trialN/A
2022-03-03 04:55 ESTNewsAscendis Pharma GAAP EPS of $7.00 beats by €15.44, revenue of €7.77M misses by $0.13MN/A
2022-03-03 04:55 ESTNewsAscendis Pharma stock falls 7% despite Q4 bottom line beatN/A
2022-03-03 04:55 ESTNewsAscendis Pharma A/S' (ASND) CEO Jan Mikkelsen on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-01 18:03 ESTNewsAscendis Pharma FY Earnings PreviewN/A
2022-01-25 06:13 ESTNewsPfizer/OPKO loss on somatrogon could boost Ascendis Pharma's fortunesN/A
2022-01-24 14:23 ESTNewsAscendis Pharma (ASND) Presents At 40th Annual J.P. Morgan Virtual Healthcare ConferenceN/A
2022-01-24 14:23 ESTNewsPfizer/OPKO loss on somatragon could boost Ascendis Pharma's fortunesN/A
2022-01-14 01:12 ESTNewsAscendis Pharma's TransCon gets EU approval for growth hormone deficiency in childrenN/A
2021-12-30 05:41 ESTNewsAscendis: Danish Biotech With Thin Audience Now Seen As Good Value By Market-MakersN/A
2021-11-19 04:06 ESTNewsPhase 2 data shows durable response of Ascendis candidate for hypoparathyroidismN/A

About Ascendis Pharma A/S (ASND):

Ascendis Pharma A/S, a biopharmaceutical company, develops therapeutics for unmet medical needs. The company develops TransCon growth hormone, which completed Phase III clinical trials for growth hormone deficiency. It also develops TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for achondroplasia. In addition, the company develops preclinical studies in the field of oncology for potential product candidates and evaluate systemic and localized delivery systems using its TransCon technologies. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.

See Advanced Chart

General

  • Name Ascendis Pharma A/S
  • Symbol ASND
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 482
  • Fiscal Year EndDecember
  • IPO Date2015-01-28
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.ascendispharma.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 917.83
  • Price/Book (Most Recent Quarter) 8.08
  • Enterprise Value Revenue 1052.08
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$8.67
  • Next Year EPS Estimate -$7.26
  • Next Quarter EPS Estimate -$2.01
  • Return on Assets -25%
  • Return on Equity -58%
  • Earnings Per Share -$5.09
  • Revenue Per Share $0
  • Gross Profit 6.95 million
  • Quarterly Earnings Growth -78.7%
View More

Highlights

  • Market Capitalization 7.87 billion
  • Analyst Target Price $194.63
  • Book Value Per Share $8.43
View More

Share Statistics

  • Shares Outstanding 53.75 million
  • Shares Float 43.76 million
  • % Held by Insiders 3%
  • % Held by Institutions 101.6%
  • Shares Short 2.48 million
  • Shares Short Prior Month 2.21 million
  • Short Ratio 11.66
  • Short % of Shares Outstanding 5%
View More

Technicals

  • Beta 0.79
  • 52 Week High $183.98
  • 52 Week Low $96.24
  • 50 Day Moving Average 152.16
  • 200 Day Moving Average 158.57
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Ascendis Pharma A/S (ASND) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Ascendis Pharma A/S (ASND) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-10$535000-$3.15-$1.87-68.17%
2020-09-302020-11-11$2.76 million-$2.72-$1.87-45.17%
2020-06-302020-08-27$1.44 million-$2.33-$1.61-44.68%
2020-03-312020-05-19$2.23 million-$1.44-$1.41-2.66%
2019-12-312019-12-31$2.51 million-$1.89-$1.62-16.67%
2019-09-302019-11-18$2.44 million-$0.59-$1.2954.34%
2019-06-302019-08-28$3.62 million-$1.38-$1.33-4.4%
2019-03-312019-05-30$6.07 million-$1.38-$1.14-20.89%
2018-12-312018-12-31$12.06 million-$0.86-$1.1424.56%
2018-09-302018-11-28$23153.51-$0.92-$1.1922.87%
2018-06-302018-08-29$20949.72-$0.64-$1.0035.45%
2018-03-312018-05-30$34444.58-$1.25-$0.88-41.8%
2017-12-312018-03-28$362000-$1.13-$0.99-14.12%
2017-09-302017-11-16$546000-$1.22-$0.86-42.4%
2017-06-302017-08-18$533000-$1.11-$0.88-26.09%
2017-03-312017-05-23$398000-$0.87-$0.76-15.03%
2016-12-312017-03-22$855000-$0.55-$0.7122.7%
2016-09-302016-11-30$1.36 million-$0.76-$0.64-19.56%
2016-06-302016-08-31$1.21 million-$0.59-$0.658.96%
2016-03-312016-04-14$1.43 million-$0.59-$0.30-95.13%
2015-09-302015-11-12$2.37 million-$0.29-$0.5648.21%
2015-06-302015-08-24$2.25 million-$0.63-$0.43-46.51%
2015-03-312015-05-18$2.24 million$0.07-$0.39117.95%
2014-12-312015-01-28$2.83 million-$0.65

Ascendis Pharma A/S (ASND) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Ascendis Pharma A/S (ASND) Chart:

Ascendis Pharma A/S (ASND) News:

Below you will find a list of latest news for Ascendis Pharma A/S (ASND) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Ascendis Pharma A/S (ASND) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-11-211400CALL0 077.18TRUE00
2025-11-2114559.5CALL0 374.46TRUE00
2025-11-211500CALL0 072.34TRUE00
2025-11-211550CALL0 071.31TRUE00
2025-11-211600CALL0 069.54TRUE00
2025-11-211650CALL0 069.11TRUE00
2025-11-211700CALL0 066.34TRUE00
2025-11-2117530.6CALL0 166.1TRUE00
2025-11-211800CALL0 062.09TRUE00
2025-11-2118521.5CALL0 159.83TRUE00
2025-11-2119018CALL0 659.43TRUE00
2025-11-2119524.8CALL0 156.58TRUE00
2025-11-2120011.93CALL0 2455.27TRUE00
2025-11-212108.71CALL0 3947.27FALSE00
2025-11-212204CALL0 1547.95FALSE00
2025-11-212302.06CALL0 1664.4FALSE00
2025-11-212401.92CALL0 369.86FALSE00
2025-11-212501CALL0 376.52FALSE00
2025-11-212600CALL0 084.87FALSE00
2025-11-212700CALL0 093FALSE00
2025-11-212800CALL0 0101.12FALSE00
2025-11-212900.22CALL0 9108.78FALSE00
2025-11-211400PUT0 0101.45FALSE00
2025-11-211450PUT0 0112.24FALSE00
2025-11-211500PUT0 0104.63FALSE00
2025-11-211552PUT0 197.03FALSE00
2025-11-211602.6PUT0 290.55FALSE00
2025-11-211651.35PUT0 184.37FALSE00
2025-11-211702.75PUT0 564.71FALSE00
2025-11-211752.5PUT0 5859.74FALSE00
2025-11-211802.65PUT149 5856.46FALSE2.650
2025-11-211853.83PUT0 458.49FALSE00
2025-11-211905PUT6 1154FALSE50
2025-11-211956.02PUT0 21254.14FALSE00
2025-11-212009.05PUT0 4051.62FALSE00
2025-11-2121015.75PUT0 2044.02TRUE00
2025-11-212200PUT0 046.23TRUE00
2025-11-212300PUT0 044TRUE00
2025-11-212400PUT0 043.52TRUE00
2025-11-2125046.5PUT0 10TRUE00
2025-11-2126056.5PUT0 00TRUE00
2025-11-2127069PUT0 00TRUE00
2025-11-212800PUT0 00TRUE00
2025-11-2129090PUT0 00TRUE00
2025-12-1960144CALL0 1143TRUE00
2025-12-19650CALL0 0125.08TRUE00
2025-12-19700CALL0 0129.57TRUE00
2025-12-19750CALL0 1119.59TRUE00
2025-12-19800CALL0 0110.17TRUE00
2025-12-19850CALL0 0101.2TRUE00
2025-12-19900CALL0 096.82TRUE00
2025-12-19950CALL0 084.11TRUE00
2025-12-191000CALL0 081.03TRUE00
2025-12-1910589CALL0 183.67TRUE00
2025-12-191100CALL0 076.96TRUE00
2025-12-1911589.5CALL0 170.51TRUE00
2025-12-191200CALL0 064.28TRUE00
2025-12-1912579.9CALL0 3866.74TRUE00
2025-12-191300CALL0 164.03TRUE00
2025-12-191350CALL0 161.03TRUE00
2025-12-191400CALL0 359.69TRUE00
2025-12-1914545.54CALL0 259.72TRUE00
2025-12-1915050.4CALL0 359.07TRUE00
2025-12-191550CALL0 057.93TRUE00
2025-12-1916043.23CALL0 6757.88TRUE00
2025-12-1916543.79CALL0 158.61TRUE00
2025-12-1917042.2CALL0 27157.85TRUE00
2025-12-1917531.9CALL0 556.48TRUE00
2025-12-1918034.23CALL0 8655.25TRUE00
2025-12-1918526.5CALL0 2954.05TRUE00
2025-12-1919021.05CALL0 554.14TRUE00
2025-12-1919521CALL0 6353.28TRUE00
2025-12-1920016.31CALL0 21051.93TRUE00
2025-12-1921011.62CALL9 36750.51FALSE11.620
2025-12-192207.5CALL0 7449.28FALSE00
2025-12-192305CALL2 29447.59FALSE50
2025-12-192406.43CALL0 1649.47FALSE00
2025-12-192502CALL0 1347.79FALSE00
2025-12-192603.2CALL0 1059.06FALSE00
2025-12-192701.9CALL0 962.01FALSE00
2025-12-192801.2CALL0 865.57FALSE00
2025-12-192900.25CALL0 1155.82FALSE00
2025-12-193000CALL0 074.46FALSE00
2025-12-193100CALL0 078.92FALSE00
2025-12-19600PUT0 0216.99FALSE00
2025-12-19650PUT0 1203.67FALSE00
2025-12-19700PUT0 0191.42FALSE00
2025-12-19750PUT0 0180.09FALSE00
2025-12-19800PUT0 20169.54FALSE00
2025-12-19850PUT0 1159.67FALSE00
2025-12-19900PUT0 21150.39FALSE00
2025-12-19950PUT0 1141.63FALSE00
2025-12-191000PUT0 1133.32FALSE00
2025-12-191052.1PUT0 3125.42FALSE00
2025-12-191102.65PUT0 4117.88FALSE00
2025-12-191150.6PUT0 0110.67FALSE00
2025-12-191200.85PUT0 2103.74FALSE00
2025-12-191251.05PUT0 097.63FALSE00
2025-12-191300PUT0 191.7FALSE00
2025-12-191351.1PUT0 186.41FALSE00
2025-12-191400.74PUT0 7682.1FALSE00
2025-12-191450PUT0 177.71FALSE00
2025-12-191500PUT0 074.37FALSE00
2025-12-191550PUT0 073.77FALSE00
2025-12-191602.36PUT0 356.6FALSE00
2025-12-191653.08PUT0 155.33FALSE00
2025-12-191704.1PUT0 31654.42FALSE00
2025-12-191750PUT0 051.17FALSE00
2025-12-191805PUT0 253.23FALSE00
2025-12-191856.07PUT0 16652.48FALSE00
2025-12-1919010.53PUT0 3051.79FALSE00
2025-12-1919517.15PUT0 151.1FALSE00
2025-12-1920013.64PUT0 1950.9FALSE00
2025-12-1921017PUT0 20148.78TRUE00
2025-12-1922023.8PUT0 445.99TRUE00
2025-12-1923035.7PUT0 143.78TRUE00
2025-12-192400PUT0 141.57TRUE00
2025-12-192500PUT0 039.94TRUE00
2025-12-1926077.4PUT0 00TRUE00
2025-12-192700PUT0 00TRUE00
2025-12-1928076.5PUT0 00TRUE00
2025-12-1929090PUT0 00TRUE00
2025-12-193000PUT0 00TRUE00
2025-12-193100PUT0 00TRUE00
2026-01-16750CALL0 092.96TRUE00
2026-01-16800CALL0 087.8TRUE00
2026-01-16850CALL0 082.92TRUE00
2026-01-16900CALL0 075.16TRUE00
2026-01-16950CALL0 078.32TRUE00
2026-01-161000CALL0 069.63TRUE00
2026-01-161050CALL0 072.49TRUE00
2026-01-161100CALL0 066.73TRUE00
2026-01-161150CALL0 062.6TRUE00
2026-01-161200CALL0 061.99TRUE00
2026-01-161250CALL0 058.85TRUE00
2026-01-161300CALL0 057.97TRUE00
2026-01-1613545.5CALL0 156.43TRUE00
2026-01-161400CALL0 054.96TRUE00
2026-01-161450CALL0 055.92TRUE00
2026-01-1615037.5CALL0 053.68TRUE00
2026-01-161550CALL0 054.15TRUE00
2026-01-1616043.47CALL0 653.19TRUE00
2026-01-1616539.75CALL0 1753.89TRUE00
2026-01-1617036.8CALL0 21152.92TRUE00
2026-01-1617540.48CALL0 552.68TRUE00
2026-01-1618031.3CALL0 752.11TRUE00
2026-01-1618528.75CALL0 21650.96TRUE00
2026-01-1619025CALL0 849.88TRUE00
2026-01-1619525.48CALL0 1048.96TRUE00
2026-01-1620020.73CALL0 4848.73TRUE00
2026-01-1621015.73CALL0 2046.76FALSE00
2026-01-1622016CALL0 345.45FALSE00
2026-01-162307.2CALL0 43245.76FALSE00
2026-01-162404.8CALL1 152043.16FALSE4.80
2026-01-162507.11CALL0 443.58FALSE00
2026-01-162603.76CALL0 143.04FALSE00
2026-01-162700CALL0 045.35FALSE00
2026-01-162801.6CALL0 455.85FALSE00
2026-01-162901.25CALL0 358.06FALSE00
2026-01-163000CALL0 060.71FALSE00
2026-01-16750PUT0 0143.5FALSE00
2026-01-16800PUT0 0135.12FALSE00
2026-01-16850PUT0 0127.27FALSE00
2026-01-16900PUT0 0119.9FALSE00
2026-01-16950PUT0 0112.93FALSE00
2026-01-161000PUT0 0106.33FALSE00
2026-01-161050PUT0 0100.6FALSE00
2026-01-161100.75PUT0 294.58FALSE00
2026-01-161150PUT0 089.8FALSE00
2026-01-161200PUT0 084.69FALSE00
2026-01-161250PUT0 080.58FALSE00
2026-01-161300PUT0 576.51FALSE00
2026-01-161355.23PUT0 2772.82FALSE00
2026-01-161403.78PUT0 1970.09FALSE00
2026-01-161450PUT0 1466.88FALSE00
2026-01-161502.47PUT0 1055.3FALSE00
2026-01-161553.04PUT0 252.27FALSE00
2026-01-161603.06PUT0 451.62FALSE00
2026-01-161656.8PUT0 2451.01FALSE00
2026-01-161707PUT0 1650.58FALSE00
2026-01-1617526.1PUT0 150.12FALSE00
2026-01-161807.55PUT0 1349.7FALSE00
2026-01-1618510PUT0 22648.79FALSE00
2026-01-1619014.49PUT0 747.75FALSE00
2026-01-1619523.7PUT0 847.28FALSE00
2026-01-1620015.4PUT0 1246.87FALSE00
2026-01-1621020.1PUT0 245.41TRUE00
2026-01-162200PUT0 044.2TRUE00
2026-01-162300PUT0 042.9TRUE00
2026-01-162400PUT0 040.94TRUE00
2026-01-162500PUT0 039.66TRUE00
2026-01-162600PUT0 041.77TRUE00
2026-01-162700PUT0 039.66TRUE00
2026-01-1628076.3PUT0 00TRUE00
2026-01-1629092.6PUT0 00TRUE00
2026-01-163000PUT0 00TRUE00
2026-04-17100102.5CALL0 059.42TRUE00
2026-04-171050CALL0 056.59TRUE00
2026-04-1711093CALL0 055.92TRUE00
2026-04-171150CALL0 055.22TRUE00
2026-04-171200CALL0 053.74TRUE00
2026-04-171250CALL0 053.32TRUE00
2026-04-1713075CALL0 054.02TRUE00
2026-04-171350CALL0 053.8TRUE00
2026-04-171400CALL0 052.73TRUE00
2026-04-171450CALL0 052.31TRUE00
2026-04-1715061.7CALL0 152.66TRUE00
2026-04-171550CALL0 052.08TRUE00
2026-04-171600CALL0 050.92TRUE00
2026-04-171650CALL0 050.94TRUE00
2026-04-171700CALL0 050.22TRUE00
2026-04-1717539.62CALL0 1750.36TRUE00
2026-04-171800CALL0 049.51TRUE00
2026-04-171850CALL0 048.92TRUE00
2026-04-1719033.21CALL0 548.45TRUE00
2026-04-171950CALL0 048.2TRUE00
2026-04-1720031.3CALL0 1047.47TRUE00
2026-04-1721024.5CALL0 446.55FALSE00
2026-04-172200CALL0 045.33FALSE00
2026-04-1723019.38CALL0 244.67FALSE00
2026-04-172400CALL0 043.98FALSE00
2026-04-172500CALL0 043.34FALSE00
2026-04-172600CALL0 042.75FALSE00
2026-04-172700CALL0 042.49FALSE00
2026-04-172804.9CALL0 141.71FALSE00
2026-04-172902.6CALL0 441.45FALSE00
2026-04-173002.7CALL0 441.14FALSE00
2026-04-173103.4CALL0 341.84FALSE00
2026-04-171000PUT0 075.15FALSE00
2026-04-171050PUT0 071.83FALSE00
2026-04-171102.15PUT0 169.21FALSE00
2026-04-171152.7PUT0 166.84FALSE00
2026-04-171200PUT0 054.08FALSE00
2026-04-171251.65PUT0 154.56FALSE00
2026-04-171302.1PUT0 151.32FALSE00
2026-04-171353.01PUT0 251.5FALSE00
2026-04-171400PUT0 051.02FALSE00
2026-04-171450PUT0 050.62FALSE00
2026-04-171500PUT0 049.92FALSE00
2026-04-171550PUT0 049.67FALSE00
2026-04-171600PUT0 049.45FALSE00
2026-04-171650PUT0 048.73FALSE00
2026-04-1717010.8PUT0 248.45FALSE00
2026-04-171750PUT0 048.62FALSE00
2026-04-1718011.6PUT0 247.77FALSE00
2026-04-1718518.04PUT0 047.48FALSE00
2026-04-1719015.01PUT0 1047.18FALSE00
2026-04-171950PUT0 046.68FALSE00
2026-04-172000PUT0 046.46FALSE00
2026-04-172100PUT0 045.43TRUE00
2026-04-172200PUT0 044.22TRUE00
2026-04-172300PUT0 043.29TRUE00
2026-04-172400PUT0 042.38TRUE00
2026-04-172500PUT0 041.82TRUE00
2026-04-172600PUT0 041.32TRUE00
2026-04-172700PUT0 040.67TRUE00
2026-04-172800PUT0 040.42TRUE00
2026-04-172900PUT0 039.78TRUE00
2026-04-173000PUT0 040.84TRUE00
2026-04-17310112.1PUT0 00TRUE00
2026-06-18800CALL0 060.58TRUE00
2026-06-18850CALL0 061.29TRUE00
2026-06-18900CALL0 058.73TRUE00
2026-06-18950CALL0 055.67TRUE00
2026-06-181000CALL0 055.17TRUE00
2026-06-181050CALL0 055.73TRUE00
2026-06-181100CALL0 055.87TRUE00
2026-06-181150CALL0 054.94TRUE00
2026-06-181200CALL0 053.04TRUE00
2026-06-181250CALL0 053.65TRUE00
2026-06-181300CALL0 053.51TRUE00
2026-06-181350CALL0 052.84TRUE00
2026-06-1814069.1CALL0 1152.37TRUE00
2026-06-181450CALL0 051.9TRUE00
2026-06-181500CALL0 051.42TRUE00
2026-06-1815551.5CALL0 251.05TRUE00
2026-06-1816049CALL0 250.32TRUE00
2026-06-1816536.9CALL0 250.43TRUE00
2026-06-1817037CALL0 1050.15TRUE00
2026-06-1817542.7CALL0 149.83TRUE00
2026-06-1818045CALL0 1549.1TRUE00
2026-06-1818531.8CALL0 148.62TRUE00
2026-06-1819035.5CALL0 1148.29TRUE00
2026-06-1819535.8CALL0 347.83TRUE00
2026-06-1820025.84CALL0 647.42TRUE00
2026-06-1821027.8CALL0 1346.2FALSE00
2026-06-1822028.24CALL0 445.42FALSE00
2026-06-1823018.5CALL0 444.54FALSE00
2026-06-1824015.95CALL0 143.6FALSE00
2026-06-1825013CALL0 2142.94FALSE00
2026-06-182600CALL0 042.03FALSE00
2026-06-182700CALL0 041.36FALSE00
2026-06-182800CALL0 040.96FALSE00
2026-06-182900CALL0 040.63FALSE00
2026-06-183000CALL0 039.9FALSE00
2026-06-183103.4CALL0 239.38FALSE00
2026-06-18800PUT0 069.5FALSE00
2026-06-18850PUT0 076.27FALSE00
2026-06-18900PUT0 072.98FALSE00
2026-06-18950PUT0 069.8FALSE00
2026-06-181000PUT0 067.3FALSE00
2026-06-181050PUT0 064.81FALSE00
2026-06-181100PUT0 053.63FALSE00
2026-06-181150PUT0 053.89FALSE00
2026-06-181200PUT0 051.65FALSE00
2026-06-181254PUT0 450.98FALSE00
2026-06-181309.08PUT0 050.32FALSE00
2026-06-181350PUT0 049.91FALSE00
2026-06-181400PUT0 049.89FALSE00
2026-06-181450PUT0 049.51FALSE00
2026-06-1815016.25PUT0 248.97FALSE00
2026-06-1815522.5PUT0 148.53FALSE00
2026-06-1816016.2PUT0 248.62FALSE00
2026-06-1816525.21PUT0 248.4FALSE00
2026-06-1817013.1PUT1 547.02FALSE13.10
2026-06-1817514PUT0 4548.05FALSE00
2026-06-1818033.3PUT0 947.28FALSE00
2026-06-1818535.6PUT0 846.92FALSE00
2026-06-181900PUT0 046.76FALSE00
2026-06-1819530.4PUT0 146.05FALSE00
2026-06-1820044.5PUT0 245.78FALSE00
2026-06-1821038.5PUT0 145.03TRUE00
2026-06-182200PUT0 043.92TRUE00
2026-06-182300PUT0 043.2TRUE00
2026-06-182400PUT0 042.14TRUE00
2026-06-182500PUT0 041.36TRUE00
2026-06-1826090.48PUT0 26940.74TRUE00
2026-06-182700PUT0 039.84TRUE00
2026-06-182800PUT0 039.38TRUE00
2026-06-182900PUT0 038.76TRUE00
2026-06-183000PUT0 038.55TRUE00
2026-06-183100PUT0 038.26TRUE00
2026-07-171050CALL0 055.89TRUE00
2026-07-171100CALL0 055.21TRUE00
2026-07-171150CALL0 053.04TRUE00
2026-07-171200CALL0 052.41TRUE00
2026-07-171250CALL0 053.19TRUE00
2026-07-171300CALL0 052.77TRUE00
2026-07-171350CALL0 052.21TRUE00
2026-07-171400CALL0 052.1TRUE00
2026-07-171450CALL0 051.56TRUE00
2026-07-171500CALL0 051.51TRUE00
2026-07-171550CALL0 051.18TRUE00
2026-07-171600CALL0 050.72TRUE00
2026-07-171650CALL0 050.15TRUE00
2026-07-171700CALL0 049.77TRUE00
2026-07-171750CALL0 049.18TRUE00
2026-07-171800CALL0 048.67TRUE00
2026-07-171850CALL0 048.65TRUE00
2026-07-171900CALL0 047.94TRUE00
2026-07-171950CALL0 047.3TRUE00
2026-07-172000CALL0 047.19TRUE00
2026-07-172100CALL0 045.99FALSE00
2026-07-172200CALL0 044.96FALSE00
2026-07-172300CALL0 044.03FALSE00
2026-07-172400CALL0 043.07FALSE00
2026-07-172500CALL0 042.48FALSE00
2026-07-172600CALL0 041.69FALSE00
2026-07-172700CALL0 041.07FALSE00
2026-07-172800CALL0 040.71FALSE00
2026-07-172900CALL0 040FALSE00
2026-07-173000CALL0 039.15FALSE00
2026-07-171050PUT0 053.56FALSE00
2026-07-171100PUT0 054.17FALSE00
2026-07-171150PUT0 051.86FALSE00
2026-07-171200PUT0 051.36FALSE00
2026-07-171250PUT0 050.75FALSE00
2026-07-171300PUT0 050.57FALSE00
2026-07-171350PUT0 049.97FALSE00
2026-07-171400PUT0 049.69FALSE00
2026-07-171450PUT0 049.39FALSE00
2026-07-171500PUT0 049.17FALSE00
2026-07-171550PUT0 048.91FALSE00
2026-07-171600PUT0 048.29FALSE00
2026-07-171650PUT0 048.26FALSE00
2026-07-171700PUT0 047.69FALSE00
2026-07-171750PUT0 047.64FALSE00
2026-07-171800PUT0 047.18FALSE00
2026-07-171850PUT0 046.94FALSE00
2026-07-171900PUT0 046.42FALSE00
2026-07-171950PUT0 045.79FALSE00
2026-07-172000PUT0 045.29FALSE00
2026-07-172100PUT0 044.56TRUE00
2026-07-172200PUT0 043.55TRUE00
2026-07-172300PUT0 042.86TRUE00
2026-07-172400PUT0 041.83TRUE00
2026-07-172500PUT0 040.91TRUE00
2026-07-172600PUT0 040.32TRUE00
2026-07-172700PUT0 039.5TRUE00
2026-07-172800PUT0 039.35TRUE00
2026-07-172900PUT0 038.44TRUE00
2026-07-173000PUT0 038.08TRUE00

Latest ASND Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST100$79.93
Jun 13, 2022 7:59 PM EST4$79.91
Jun 13, 2022 7:59 PM EST118$79.93
Jun 13, 2022 7:59 PM EST9$79.97
Jun 13, 2022 7:59 PM EST17$79.97

Ascendis Pharma A/S (ASND) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520185199/0001193125-20-185199-index.htm
2019-06-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000008025519002847/0000080255-19-002847-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000008025520001284/0000080255-20-001284-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000031506620000822/0000315066-20-000822-index.htm
2019-03-12SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787119000203/0000947871-19-000203-index.htm
2019-08-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787119000594/0000947871-19-000594-index.htm
2020-03-05SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787120000185/0000947871-20-000185-index.htm
2020-05-08SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787120000446/0000947871-20-000446-index.htm
2020-05-22SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787120000511/0000947871-20-000511-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000110465920021751/0001104659-20-021751-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000110465920021912/0001104659-20-021912-index.htm
2020-09-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000110465920103962/0001104659-20-103962-index.htm
2019-02-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519042416/0001193125-19-042416-index.htm
2019-03-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519059442/0001193125-19-059442-index.htm
2019-03-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519061604/0001193125-19-061604-index.htm
2019-03-04424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312519062499/0001193125-19-062499-index.htm
2019-03-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312519065750/0001193125-19-065750-index.htm
2019-03-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519069120/0001193125-19-069120-index.htm
2019-03-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519074983/0001193125-19-074983-index.htm
2019-04-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519096618/0001193125-19-096618-index.htm
2019-04-0320-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1612042/000119312519096759/0001193125-19-096759-index.htm
2019-04-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519105316/0001193125-19-105316-index.htm
2019-04-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519112380/0001193125-19-112380-index.htm
2019-05-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519133019/0001193125-19-133019-index.htm
2019-05-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519149447/0001193125-19-149447-index.htm
2019-05-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519161327/0001193125-19-161327-index.htm
2019-05-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519161365/0001193125-19-161365-index.htm
2019-06-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519173846/0001193125-19-173846-index.htm
2019-06-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519175289/0001193125-19-175289-index.htm
2019-06-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519181943/0001193125-19-181943-index.htm
2019-07-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519187411/0001193125-19-187411-index.htm
2019-07-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519191873/0001193125-19-191873-index.htm
2019-07-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519196527/0001193125-19-196527-index.htm
2019-08-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519221217/0001193125-19-221217-index.htm
2019-08-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519232458/0001193125-19-232458-index.htm
2019-09-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519244911/0001193125-19-244911-index.htm
2019-09-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519255970/0001193125-19-255970-index.htm
2019-10-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519263919/0001193125-19-263919-index.htm
2019-10-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519265843/0001193125-19-265843-index.htm
2019-11-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519292336/0001193125-19-292336-index.htm
2019-11-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519293431/0001193125-19-293431-index.htm
2019-11-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519294735/0001193125-19-294735-index.htm
2019-12-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519312728/0001193125-19-312728-index.htm
2020-01-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520002169/0001193125-20-002169-index.htm
2020-01-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520005786/0001193125-20-005786-index.htm
2020-01-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520008093/0001193125-20-008093-index.htm
2020-02-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520033240/0001193125-20-033240-index.htm
2020-03-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520071551/0001193125-20-071551-index.htm
2020-03-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520092940/0001193125-20-092940-index.htm
2020-04-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520094591/0001193125-20-094591-index.htm
2020-04-0320-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1612042/000119312520096870/0001193125-20-096870-index.htm
2020-04-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520108208/0001193125-20-108208-index.htm
2020-04-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520111593/0001193125-20-111593-index.htm
2020-04-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520112279/0001193125-20-112279-index.htm
2020-04-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520126717/0001193125-20-126717-index.htm
2020-05-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520133706/0001193125-20-133706-index.htm
2020-05-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520142982/0001193125-20-142982-index.htm
2020-05-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520146167/0001193125-20-146167-index.htm
2020-06-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520157336/0001193125-20-157336-index.htm
2020-06-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520167815/0001193125-20-167815-index.htm
2020-06-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520180048/0001193125-20-180048-index.htm
2020-07-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520185199/0001193125-20-185199-index.htm
2020-07-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520187456/0001193125-20-187456-index.htm
2020-07-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312520187810/0001193125-20-187810-index.htm
2020-07-09424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312520190428/0001193125-20-190428-index.htm
2020-07-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520191149/0001193125-20-191149-index.htm
2020-07-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520194325/0001193125-20-194325-index.htm
2020-08-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520219118/0001193125-20-219118-index.htm
2020-08-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520233148/0001193125-20-233148-index.htm
2020-09-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520241091/0001193125-20-241091-index.htm
2020-09-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520243078/0001193125-20-243078-index.htm
2020-09-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520252366/0001193125-20-252366-index.htm
2020-09-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520257235/0001193125-20-257235-index.htm
2020-09-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520257292/0001193125-20-257292-index.htm
2020-10-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520263856/0001193125-20-263856-index.htm
2020-10-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000119312520265872/0001193125-20-265872-index.htm
2020-10-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520270385/0001193125-20-270385-index.htm
2020-10-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520275018/0001193125-20-275018-index.htm
2019-10-23SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000121390019020915/0001213900-19-020915-index.htm
2019-02-22CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1612042/999999999719000498/9999999997-19-000498-index.htm
2020-07-15CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1612042/999999999720004106/9999999997-20-004106-index.htm